Feedback / Questions
barzolvolimab (CDX-0159) - Celldex
https://www.globenewswire.com/news-release/2026/07/21/3330938/24180/en/Celldex-Reports-Results-from-Phase-2-Study-of-Barzolvolimab-in-Prurigo-Nodularis.html
Jul 21, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next